Literature DB >> 21750154

Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).

Stella Edström Halling1, Magnus P Söderberg, Ulla B Berg.   

Abstract

BACKGROUND: There has been a lack of international consensus on the classification and the predictive value of the histopathology findings in IgA nephropathy (IgAN). Recently, the International IgA Nephropathy Network has developed the Oxford classification in which four histological variables with the most prognostic importance are identified (MEST score). Our objective was to validate these findings and to assess their predictive power in our cohort and to compare them to identified clinical predictors.
METHODS: Ninety-nine children with a follow-up time >5 years were included and investigated with clearances of inulin or iohexol for glomerular filtration rate (GFR), proteinuria and blood pressure at biopsy and during follow-up. Biopsies (90/99) were re-evaluated and scored according to the Oxford classification.
RESULTS: Eighteen patients progressed to a poor outcome [end-stage renal disease (ESRD) or GFR reduction >50%]. In the univariate analysis, we found that mesangial hypercellullarity score >0.5, presence of endocapillary hypercellularity or tubular atrophy/interstitial fibrosis of >25% were each associated with a poor outcome, and also presence of cellular or fibrocellular crescents and of global glomerulosclerosis, but segmental glomerulosclerosis did not reach statistical significance. The clinical predictors of a poor outcome were a low GFR, a high mean arterial blood pressure and a high amount of albuminuria (log Ualb/c) at time of biopsy and low GFR and a high log Ualb/c during follow-up.
CONCLUSION: We found that three of the four histology lesions identified in the Oxford classification, as well as presence of crescents, were valid in predicting a poor outcome in our cohort of patients.

Entities:  

Mesh:

Year:  2011        PMID: 21750154     DOI: 10.1093/ndt/gfr339

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  39 in total

1.  Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch-Schönlein purpura and primary IgA nephropathy.

Authors:  Maria Elena Donadio; Elisa Loiacono; Licia Peruzzi; Alessandro Amore; Roberta Camilla; Federica Chiale; Luca Vergano; Alberto Boido; Margherita Conrieri; Manuela Bianciotto; Francesca Maria Bosetti; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2014-04-01       Impact factor: 3.714

Review 2.  Immunoglobulin A nephropathy: a pathophysiology view.

Authors:  Rafaela Cabral Gonçalves Fabiano; Sérgio Veloso Brant Pinheiro; Ana Cristina Simões E Silva
Journal:  Inflamm Res       Date:  2016-06-28       Impact factor: 4.575

3.  Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.

Authors:  Ke Xu; Lili Zhang; Jie Ding; Suxia Wang; Baige Su; Huijie Xiao; Fang Wang; Xuhui Zhong; Yanming Li
Journal:  J Nephrol       Date:  2017-11-28       Impact factor: 3.902

Review 4.  Pathology of IgA nephropathy.

Authors:  Ian S D Roberts
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

5.  Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura.

Authors:  Camille Dumont; Aicha Mérouani; Thierry Ducruet; Geneviève Benoit; Marie-Josée Clermont; Anne Laure Lapeyraque; Véronique Phan; Natalie Patey
Journal:  Pediatr Nephrol       Date:  2020-01-13       Impact factor: 3.714

6.  Validity of the Oxford classification of IgA nephropathy in children.

Authors:  Yuko Shima; Koichi Nakanishi; Taketsugu Hama; Hironobu Mukaiyama; Hiroko Togawa; Yuya Hashimura; Hiroshi Kaito; Mayumi Sako; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2011-12-02       Impact factor: 3.714

Review 7.  Treatment of IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2013-04-02       Impact factor: 28.314

8.  Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2016-01-06

9.  Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.

Authors:  Koichi Kamei; Koichi Nakanishi; Shuichi Ito; Kenji Ishikura; Hiroshi Hataya; Masataka Honda; Kandai Nozu; Kazumoto Iijima; Yuko Shima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2014-12-10       Impact factor: 3.714

10.  A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.

Authors:  Mark Haas; Jacobien C Verhave; Zhi-Hong Liu; Charles E Alpers; Jonathan Barratt; Jan U Becker; Daniel Cattran; H Terence Cook; Rosanna Coppo; John Feehally; Antonello Pani; Agnieszka Perkowska-Ptasinska; Ian S D Roberts; Maria Fernanda Soares; Hernan Trimarchi; Suxia Wang; Yukio Yuzawa; Hong Zhang; Stéphan Troyanov; Ritsuko Katafuchi
Journal:  J Am Soc Nephrol       Date:  2016-09-09       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.